Table 2.
Summary of seizure freedom by seizure semiology and type of therapy
| Total, N (%)a | Seizure free (% from total) | |
|---|---|---|
| Patients with FBDS | 35 | 23 |
| Received immunotherapyb | 30 (88) | 20 (67) |
| Received AEDsb | 34 (97) | 3 (9) |
| Patients with non‐FBDS | 21 | 15 |
| Received immunotherapyb | 20 (95) | 9 (42) |
| Received AED(s)b | 21 (100) | 6 (28) |
| Patients with use of NCB AEDb | 52 | 4c |
| Patients with use of non‐NCB AEDb | 83 | 0c |
AED, antiepileptic drug; FBDS, focal aware faciobrachial dystonic seizures; NCB AED, sodium channel blocking antiepileptic drugs.
a
Multiple therapies within the same patient were used in most cases.
b
Received therapy during the course of their illness.
c
Included only those patients who responded to either AEDs alone or with AEDs prior to initiation of immunotherapy.